Erythromycin in the treatment of acute bronchitis in a community practice.

Abstract

To assess the efficacy of erythromycin in treating acute bronchitis, 52 adults were enrolled in a randomized trial comparing a one-week course of erythromycin with placebo. Among smokers, no difference in outcome was noted. Among nonsmokers, trends favored more rapid resolution of key symptoms in the erythromycin group, but these trends did not generally achieve statistical significance. These results suggest a trial with a larger sample size.

• Authors: F X Brickfield, W H Carter, R E Johnson
• Journal: The Journal of family practice (J Fam Pract) Vol. 23 Issue 2 Pg. 119-22 (Aug 1986) ISSN: 0094-3509 [Print] United States
• PMID: 3525736 (Publication Type: Clinical Trial, Comparative Study, Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't)

Chemical References

• Erythromycin

Topics

• Acute Disease
• Adult
• Bronchitis (drug therapy)
• Clinical Trials as Topic
• Double-Blind Method
• Erythromycin (therapeutic use)
• Family Practice
• Female
• Humans
• Male
• Prospective Studies
• Random Allocation
• Smoking